Growth Hormone, Insulin-Like Growth Factor-1, Insulin Resistance, and Leukocyte Telomere Length as Determinants of Arterial Aging in Subjects Free of Cardiovascular Diseases

被引:15
|
作者
Strazhesko, Irina D. [1 ,2 ]
Tkacheva, Olga N. [3 ]
Akasheva, Dariga U. [4 ]
Dudinskaya, Ekaterina N. [3 ]
Plokhova, Ekaterina V. [5 ]
Pykhtina, Valentina S. [3 ]
Kruglikova, Anna S. [6 ]
Brailova, Natalia V. [3 ]
Sharashkina, Natalia V. [3 ]
Kashtanova, Daria A. [3 ]
Isaykina, Olesya Y. [7 ]
Pokrovskaya, Mariya S. [8 ]
Vygodin, Vladimir A. [9 ]
Ozerova, Irina N. [10 ]
Skvortsov, Dmitry A. [11 ]
Boytsov, Sergey A. [12 ]
机构
[1] Minist Healthcare Russian Federat, Natl Med Res Ctr Prevent Med, Fed State Inst, Dept Clin Cardiol & Mol Genet, Moscow, Russia
[2] Lomonosov Moscow State Univ, Med Sci & Educ Ctr, Dept Age Associated Dis, Moscow, Russia
[3] Pirogov Russian Natl Res Med Univ, Russian Clin Res Ctr Gerontol, Moscow, Russia
[4] Minist Healthcare Russian Federat, Natl Med Res Ctr Prevent Med, Fed State Inst, Dept Fundamental & Appl Aspects Obes, Moscow, Russia
[5] Fed Medicobiol Agcy, Fed Sci & Clin Ctr, Dept Cardiol, Moscow, Russia
[6] Minist Healthcare Russian Federat, Natl Med Res Ctr Prevent Med, Fed State Inst, Dept Aging & Age Associated Dis Prevent, Moscow, Russia
[7] Minist Healthcare Russian Federat, Natl Med Res Ctr Prevent Med, Fed State Inst, Dept Primary Prevent Chron Non Communicable Dis H, Moscow, Russia
[8] Minist Healthcare Russian Federat, Natl Med Res Ctr Prevent Med, Fed State Inst, Biobank, Moscow, Russia
[9] Minist Healthcare Russian Federat, Natl Med Res Ctr Prevent Med, Dept Epidemiol Chron Non Communicable Dis, Lab Biostat,Fed State Inst, Moscow, Russia
[10] Minist Healthcare Russian Federat, Natl Med Res Ctr Prevent Med, Dept Biochem Markers Chron Non Communicable Dis R, Fed State Inst, Moscow, Russia
[11] Lomonosov Moscow State Univ, Dept Chem, Moscow, Russia
[12] Minist Healthcare Russian Federat, Natl Med Res Ctr Cardiol, Moscow, Russia
来源
FRONTIERS IN GENETICS | 2017年 / 8卷
关键词
arterial aging; growth hormone; insulin-like growth factor-1; insulin resistance; leukocytes telomeres length; 3RD NATIONAL-HEALTH; METABOLIC SYNDROME; LIFE-SPAN; MYOCARDIAL-INFARCTION; OLDER-ADULTS; RISK-FACTORS; ALL-CAUSE; IGF-I; ATHEROSCLEROSIS; ASSOCIATION;
D O I
10.3389/fgene.2017.00198
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Increased arterial stiffness (AS), intima-media thickness (IMT), and the presence of atherosclerotic plaques (PP) have been considered as important aspects of vascular aging. It is well documented that the cardiovascular system is an important target organ for growth hormone (GH) and insulin-like growth factor (IGF)-1 in humans, and GH/IGF-1 deficiency significantly increases the risk for cardiovascular diseases (CVD). The telomere length of peripheral blood leukocytes (LTL) is a biomarker of cellular senescence and that has been proposed as an independent predictor of (CVD). The aim of this study is to determine the role of GH/IGF-1, LTL and their interaction cardiovascular risk factors (CVRF) in the vascular aging. Methods: The study group included 303 ambulatory participants free of known CVD (104 males and 199 females) with a mean age of 51.8 +/- 13.3 years. All subjects had one or more CVRF [age, smoking, arterial hypertension, obesity, dyslipidemia, fasting hyperglycemia, insulin resistance-HOMA (homeostatic model assessment) >2.5, or high glycated hemoglobin]. The study sample was divided into the two groups according to age as "younger" (m <= 45 years, f <= 55 years) and "older" (m > 45 years, f > 55 years). IMT and PP were determined by ultrasonography, AS was determined by measuring the carotid-femoral pulse wave velocity (c-f PWV) using the SphygmoCor system (AtCor Medical). LTL was determined by PCR. Serum IGF-1 and GH concentrations we measured by immunochemiluminescence analysis. Results: Multiple linear regression analysis with adjustment for CVRF indicated that HOMA, GH, IGF-1, and LTL had an independent relationship with all the arterial wall parameters investigated in the younger group. In the model with c-f PWV as a dependent variable, p < 0.001 for HOMA, p = 0.03 for GH, and p = 0.004 for LTL. In the model with IMT as a dependent variable, p = 0.0001 for HOMA, p = 0.044 for GH, and p = 0.004 for IGF-1. In the model with the number of plaques as a dependent variable, p = 0.0001 for HOMA, and p = 0.045 for IGF-1. In the older group, there were no independent significant associations between GH/IGF-1, LTL, HOMA, and arterial wall characteristics. Conclusions: GH/IGF-1, IR, HOMA, and LTL were the important parameters of arterial aging in younger healthy participants.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Growth hormone, insulin-like growth factor-1 and the aging brain
    Ashpole, Nicole M.
    Sanders, Jessica E.
    Hodges, Erik L.
    Yan, Han
    Sonntag, William E.
    EXPERIMENTAL GERONTOLOGY, 2015, 68 : 76 - 81
  • [2] Insulin-Like Growth Factors and Leukocyte Telomere Length: The Cardiovascular Health Study
    Kaplan, Robert C.
    Fitzpatrick, Annette L.
    Pollak, Michael N.
    Gardner, Jeffrey P.
    Jenny, Nancy S.
    McGinn, Aileen P.
    Kuller, Lewis H.
    Strickler, Howard D.
    Kimura, Masayuki
    Psaty, Bruce M.
    Aviv, Abraham
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2009, 64 (11): : 1103 - 1106
  • [3] Growth hormone, insulin, and insulin-like growth factor-1 in hypermobility syndrome
    Denko, CW
    Boja, B
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (07) : 1666 - 1669
  • [4] THE ROLE OF GROWTH HORMONE - INSULIN LIKE GROWTH FACTOR-1 AXIS IN AGING
    Piotrowska, Katarzyna
    Sluczanowska-Glabowska, Sylwia
    Staniszewska, Marzena
    Banach, Boleslaw
    Glabowski, Wojciech
    Laszczynska, Maria
    Ratajczak, Mariusz Z.
    POSTEPY BIOLOGII KOMORKI, 2014, 41 (04) : 651 - 666
  • [5] The effects of growth hormone and insulin-like growth factor-1 on the aging cardiovascular system and its progenitor cells
    Devin, Jessica K.
    Young, Pampee P.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (09) : 983 - 992
  • [6] Diverse Roles of Growth Hormone and Insulin-Like Growth Factor-1 in Mammalian Aging: Progress and Controversies
    Sonntag, William E.
    Csiszar, Anna
    deCabo, Raphael
    Ferrucci, Luigi
    Ungvari, Zoltan
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2012, 67 (06): : 587 - 598
  • [7] The Fascinating Interplay between Growth Hormone, Insulin-Like Growth Factor-1, and Insulin
    Nijenhuis-Noort, Eline C.
    Berk, Kirsten A.
    Neggers, Sebastian J. C. M. M.
    van der Lely, Aart J.
    ENDOCRINOLOGY AND METABOLISM, 2024, 39 (01) : 83 - 89
  • [8] Chronic inflammation and the growth hormone/insulin-like growth factor-1 axis
    Witkowska-Sedek, Ewelina
    Pyrzak, Beata
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2020, 45 (04) : 469 - 475
  • [9] Doxorubicin Impairs the Insulin-Like Growth Factor-1 System and Causes Insulin-Like Growth Factor-1 Resistance in Cardiomyocytes
    Fabbi, Patrizia
    Spallarossa, Paolo
    Garibaldi, Silvano
    Barisione, Chiara
    Mura, Marzia
    Altieri, Paola
    Rebesco, Barbara
    Monti, Maria Gaia
    Canepa, Marco
    Ghigliotti, Giorgio
    Brunelli, Claudio
    Ameri, Pietro
    PLOS ONE, 2015, 10 (05):
  • [10] The aging brain: is function dependent on growth hormone/insulin-like growth factor-1 signaling?
    Forshee, B. A.
    AGE, 2006, 28 (02) : 173 - 180